Syed Adnan Ali

Dr. Syed Adnan Ali is a Research Fellow at the Australian National University (ANU) within the John Curtin School of Medical Research (JCSMR), specifically in the Genome Sciences and Cancer Division. His research focuses on prostate cancer biology, genomics, and clinical oncology, with a particular emphasis on metastatic disease progression, treatment responses, and biomarkers. He is actively involved in large-scale clinical trials such as STAMPEDE, investigating therapies like abiraterone and radiotherapy in metastatic prostate cancer. His work also extends to malaria research, exploring genetic factors influencing disease susceptibility. Dr. Ali holds an MBBS and PhD, contributing to both translational and basic science research in oncology and infectious diseases.

Education: MBBS (Medical Degree), PhD in relevant biomedical sciences.

Research Interests: Prostate cancer metastasis, genomic profiling of tumors, radiation therapy efficacy, clinical trial design, and malaria pathogenesis. His studies often bridge molecular mechanisms with clinical outcomes, aiming to improve patient stratification and treatment strategies.

Key Projects: STAMPEDE trial follow-ups, genomic analyses of metastatic prostate cancer, and investigations into bone scan indices predicting radiotherapy response. His malaria research includes studying calcium ATPase roles in parasite interactions.

Awards: Not explicitly listed in the provided information.

Grants/Advising: Collaborates on major clinical studies and likely holds grants related to prostate cancer and malaria research. Advises on multidisciplinary teams within JCSMR and the Clinical Hub for Interventional Research (CHOIR).

Labs/Teams: Part of the Polizzotto Group within CHOIR and the Genome Sciences and Cancer Division, contributing to collaborative research environments addressing critical healthcare challenges.